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From the Core to the Peripheries: Multilateral Governance of
Malaria in a Multi-Cultural World
Obijiofor Aginam*
I. INTRODUCTION: THE NEW MULTILATERAL
INITIATIVE ON MALARIA
The election of Gro Harlem Brundtland, former Prime Minister of Norway and
former Chair of the World Commission on Environment and Development
("Brundtland Commission"), as the Director General of the World Health
Organization ("WHO") in 1998 was widely regarded by the public health community
as the dawn of a new era. The "Brundtland Era," most experts and commentators
predicted, would radically reform the WHO, allowing it to reclaim its lost mandate as
the directing and coordinating authority on international health work. This important
mandate, in the decade preceding 1998, had been significantly eroded as a result of
years of inefficiency and excessive bureaucracy.' The commentators also predicted that
the Brundtland Era would reposition the WHO within the normative framework of
global health governance. In the matrix of this multilateral framework, the WHO was
to emerge as the champion and initiator (not a grudging follower) of multilateral
efforts aimed at the increased use of normative and legal interventions in global health
work, an initiative the WHO had appallingly discarded in the decades following its
creation in 1948.
Assistant Professor of Law, Carleton University, Ottawa, Canada. My sincere thanks to Professors
Ivan L. Head, Stephan Salzberg, and Karin Mickelson for their comments on aspects of this article;
Dr. IPS Okafor for his perspectives on the challenges of rural medical practice in Nigeria. I should
also like to thank Professor Maurice Iwu, Dr. Douglas Bettcher of the World Health Organization,
Geneva, Professor Obiora C. Okafor, and Dr. Ikechi Mgbeoji for their intellectual support over the
years; and Professors David P. Fidler (Indiana University School of Law) and Jack Goldsmith
(University of Chicago School of Law), and the editors of the Chicago Journal of International Law for
inviting me to contribute to this issue of the journal. I dedicate this article to billions of innocent
African children whose daily lives, for no reason other than the place of their birth, are constantly
threatened by malaria and other associated pathogenic forces.
1. See generally The Brundtland Era Begins, 351 Lancet 381 (Feb 7, 1998).
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True to expert predictions, the Brundtland Era has boldly revisited the treaty-
making powers of the WHO under Article 19 of its constitution. It has also launched
an initiative on the multilateral governance of malaria, a long neglected disease that
takes its toll on billions of lives in the global South. Steered by Brundtland's
leadership at the WHO, malaria is now the subject of an innovative public-private
global partnership led by the WHO, called the Roll-Back Malaria Campaign
("RBM").
This article discusses multilateral malaria control strategy, the RBM, its
mission, vision, and relationship with traditional therapies in malaria-endemic
societies, especially in Africa, where malaria is one of the biggest contributors to the
burdens of disease. Because big multilateral partnerships like the RBM are almost
always guilty of the charges of non-transparency, non-responsiveness, and insensitivity
to the local constituencies they serve, I use Richard Falk's twin concepts of"globalism-
from-above" and "globalism-from-below" to explore the interaction between the RBM
and traditional therapies in malaria-endemic societies. In search of a transparent
cosmopolitan malaria regime, I propose a transnational dialogue between all the
relevant actors and stakeholders: multilateral health institutions, pharmaceutical
corporations, indigenous populations, traditional healers, and civil society. We need
to synthesize the tension between the core (policies of multilateral institutions) and
the peripheries (traditional therapies in malaria-endemic societies). This synthesis
must proceed in a way that projects multilateralization of malaria as a humane
enterprise rather than a predator that erodes age-long therapies of rural populations in
malaria-endemic societies of the global South.
II. RBM: HISTORY, MISSION, AND VISION
The WHO launched a global campaign to eradicate malaria in 1955. In 1969,
when it abandoned the eradication strategy, malaria had been completely eliminated
from the industrialized countries where it hitherto had been endemic. Parts of Asia
and Latin America witnessed significant reductions in malaria morbidity. In Africa,
the WHO's eradication campaign was focused only on Ethiopia, South Africa, and
Zimbabwe because "eradication was considered not yet feasible in the other
countries."3 Globally, Africa continues to bear the heaviest burden of malaria mortality
and morbidity.
Malaria is most serious in the poorest countries and among populations living
under impoverished conditions. It undermines the health and welfare of families,
2. Consider Richard Falk, Law in an Emerging Global Village (Transnational 1998); Richard Falk, The
Making of Global Citizenship, in Jeremy Brecher, John Brown, and Jill Cutler, eds, Global Visions:
Beyond the New World Order 39 (South End 1993).
3. Peter Trigg and Anatoli Kondrachine, The Global Malaria Control Strategy, 3 World Health: The
Magazine of the WHO 4 (May-June 1998).
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endangers the survival of children, debilitates the active populations, and impoverishes
individuals and countries. As such, malaria is a health problem that is inextricably
linked to the social and economic development of African societies. According to the
WHO, "[m]alaria and underdevelopment are closely intertwined.... The disease
causes widespread premature death and suffering, imposes financial hardship on poor
households, and holds back economic growth and improvements in living standards."4
In the early 1990s, the WHO changed its malaria policy from eradication to
control. The first Global Malaria Control Strategy was endorsed at a Ministerial
Conference on Malaria Control convened by the WHO in Amsterdam in 1992. The
United Nations General Assembly endorsed it in 1994, and the United Nations
Economic and Social Council ("ECOSOC") adopted its action plan in 1995. The four
basic elements of the global malaria control strategy are:
1) provision of early diagnosis and prompt treatment;
2) planning and implementation of selective and sustainable preventive measures
including vector control;
3) early detection, containment and prevention of outbreaks; and
4) strengthening of local capacities in basic and applied research to promote the
regular assessment of each country's malaria situation, particularly the
ecological, social, and economic determinants of the disease.5
The WHO's global malaria control strategy since 1992 was presumably
subsumed by its present RBM Campaign. RBM consolidates the experience of the
past twenty years and is committed to cutting the burden of malaria in endemic areas
in half by 2010. RBM is a partnership of agencies: the WHO, the World Bank, the
United Nations Children's Fund ("UNICEF"), and the United Nations
Development Programme ("UNDP"). Major development agencies from the US, EU,
Canada, Sweden, the Netherlands, France, Germany, Belgium, and Italy, as well as
foundations and research institutes, maintain close links with RBM.
RBM has six basic elements:
1) evidence-based decisions using surveillance, appropriate responses, and
building of community awareness;
2) rapid diagnosis and treatment;
4. World Health Organization, The World Health Report 1999: Making a Difference 49 (WHO 1999).
For a detailed discussion of the economics of malaria control, see Catherine Goodman, Paul
Coleman, and Anne Mills, Economic Analysis of Malaria Control in Sub-Sabaran Africa (Global Forum
for Health Research 2000). See also Report of the Commission on Macroeconomics and Health,
Macrocconomics and Health: Investing in Health for Economic Development (WHO 2001), available online
at <http://www.cid.harvard.edu/cidcmh/CMHReport.pdf> (visited Mar 24, 2002).
5. Trigg and Kondrachine, 3 World Health at 5 (cited in note 3). See also Christian Lengeler,
Jacqueline Cattani, and Don de Savigny, From Research to Implementation, in Christian Lengeler,
Jacqueline Cattani, and Don de Savigny, eds, Net Gain: A New Method for Preventing Malaria Deaths
1-3 (IDRC 1996).
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3) multiple prevention: better multi-pronged protection using insecticide-treated
mosquito nets, environmental management to control mosquitoes, and
methods to make pregnancy safer;
4) focused research to develop new medicines, vaccines, and insecticides and to
help epidemiological and operational activities;
5) coordinated action for strengthening existing health services and policies and
providing technical support; and
66) harmonized actions to build a dynamic global movement.
One oft-cited reason for the resurgence of malaria in Africa and other malaria-
endemic regions is drug resistance. The WHO argues that "[t]he potentially lethal
malaria parasite, P. falciparum, has shown itself capable of developing resistance to
nearly all available anti-malarial drugs. Chloroquine, perhaps the best ever antimalarial
drug, and certainly the most widely used, is now failing against falciparum malaria in
most areas of the tropical world."7 As a result, investment in the production of
effective and affordable malaria drugs is an integral part of RBM.
Prior to RBM, the Multilateral Initiative on Malaria ("MIM") in Africa was
launched in January 1997 as a coalition of the public and private sectors to promote
malaria research in Africa. As part of MIM, the UNDP, the World Bank, and the
WHO's Special Programme for Research and Training in Tropical Diseases
("TDR") are coordinating the Task Force on Malaria Research Capability and
Strengthening in Africa, which focuses on the needs of malaria-endemic countries.
With a budget of about $3 billion annually, the main research areas to be funded are
anti-malarial drug policy and chemotherapy, epidemiology, pathogenesis, vectors,
health systems, and social science. The WHO continues to be involved in the MIM
Task Force, primarily through TDR.
In November 1999, another public-private partnership for the discovery of new
anti-malarial drugs, Medicines for Malaria Venture ("MMV") was launched as a new
but autonomous partner to RBM. Initial co-sponsors of the MMV were the WHO,
the International Federation of Pharmaceutical Manufacturers Associations, the
World Bank, the UK Department for International Development, the Swiss Agency
for Development and Co-operation, the Global Forum for Health Research, the
Rockefeller Foundation, the RBM Partnership, and the Netherlands Ministry of
Development Co-operation. The goal of MMV is to secure the registration of one
new anti-malarial drug every five years. This required raising $15 million annually by
2001, with $30 million to be raised annually thereafter.
6. For an overview of the RBM project, see WHO, Roll Back Malaria, available online at
<http://www.rbm.who.int> (visited Mar 24, 2002).
7. World Health Organization, The World Health Report 1999 at 52 (cited in note 4).
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According to WHO Director-General Brundtland,
MMV has been created because the increased costs of developing and registering
pharmaceutical products, coupled with the prospects of inadequate commercial
returns, have resulted in the withdrawal of the majorit of research-based
pharmaceutical companies from R&D investment in tropical diseases and especially
from discovery research activities.8
MMV offers a new approach. It is a partnership that brings together the
pharmaceutical industry, with its knowledge and expertise in drug discovery and
development, and the public sector, with its expertise in basic biology and field
studies. MMV is a response of the private and public sectors to the growing crisis of
malaria and the high priority given to rolling back malaria by the WHO and other
partners. Through MMV, the private and public sectors are able to bring together the
best of one anothers strengths, and contribute to the RBM goal of halving the global
malaria burden by the year 2010 and sustaining this effort in the future. MMV is an
entrepreneurial non-profit venture legally incorporated as a foundation under Swiss
law. It will negotiate drug-licensing agreements in a way that recognizes the
intellectual property rights of its partners in the pharmaceutical sector. The major
goal of these agreements will be to produce medicines and medical products for low-
income populations at affordable prices. A royalty income may accrue to MMV on
products that earn significant returns for MMV's commercial partners. These returns
will feed back into MMV's fund to offset the need for future donations.9
RBM and MMV are important and innovative milestones in multilateral public
health. They represent a collaborative public-private partnership to tackle a disease
that attacks the poor, with arguably the heaviest health and economic burden endemic
within Africa." Nevertheless, both RBM and MMV, as global policies, must be
analyzed against the perceptions of local populations in Africa, where the disease is
most prevalent. If global policy is antithetical to the behavioral practices of
populations in malaria-endemic societies, then an effective synthesis must be
developed to close the regime deficit. With an aim to synthesize any apparent or
foreseeable conflicts, I analyze ethnopharmacological approaches to disease from an
African perspective.
8. World Health Organization, Partner Agencies and Industry Launch Unique Venture to Develop Malaria
Drugs (WHO Press Release Nov 3, 1999), available online at <http://www.who.inr/inf-pr-
1999/en/pr99-mmvl.hrm> (visited Mar 24,2002).
9. For general information about MMV and how it operates, see Medicines for Malaria Venture, available
online at <http://www.mmv.org> (visited Mar 24,2002).
10. See Gavin Yamey, Global Campaign to Eradicate Malaria, 322 Brit MedJ 1191 (May 19, 2001) (stating
that the RBM Campaign has had two major successes: building an impressive partnership of public,
private, and non-profit agencies, and raising the visibility of a neglected disease).
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III. ETHNOPHARMACOLOGICAL APPROACHES TO DISEASE IN
AFRICA
Ethnomedical or ethnopharmacological approaches to disease remain
controversial despite the volumes of seminal works and series of international
conferences such approaches have generated in past decades.' One source of this
controversy is science. Aspects of Western scientific discourse dismiss African
traditional medicine (including ethnomedical malaria therapies) as an unscientific
belief, magic, superstition, ritual, barbarism, witchcraft, or sorcery.
Frants Staugard observed that throughout history, an ambitious search for
physical, social, and mental well-being has preoccupied the minds of humankind in all
cultures. As a result, two systematic responses to ill-health and disease have emerged.
One is the modern system of medicine founded by Hippocrates and his pupils on the
Greek Island of Kos, and the other is traditional medicine, which is as old as human
culture. From ancient times, the two systems have coexisted, albeit with hostility.
Staugard states that modern medicine has often demonstrated its hostility towards
traditional health care by categorizing it either as "quackery" or "witchcraft.' 2 This
categorization arises from the mistaken Western view of the herbalist, diviner,
magician, and faith healer as belonging to one single and indivisible health delivery
compartment devoid of methodological or analytical scientific investigation.
Isaac Sindiga observed that most studies concerned with African traditional
medicine have linked it with beliefs, religion, and rituals. Such studies, pioneered by
the structural functional school of British anthropology, uncritically concluded that
African disease aetiologies were basically moral, social, and devoid of any scientific
insights and assessment. 3 In a recent work, De Smet wrote that "[m]any Western
11. Ethnomedicine is defined as "the study of how members of cultures think about disease and
organize themselves toward medical treatment and social organization of treatment itself." Horacio
Fabrega, Jr., The Need for an Etbnomedical Science, 189 Science 969, 969 (Sept 19, 1975). Reacting to
the question, "What is erhnopharmacology." Peter A.G.M. De Smet states that,
[flrom time immemorial, man has valued the plant kingdom and animal kingdom as
sources of bioactive products ... Some of these traditionalplant and animal substances
are purely magical. They have no relevant pharmacological .e. drug-like) effects, which
can be produced in a laboratory setting. Many substances have a measurable
pharmacological action, however, which corresponds well to their traditional application.
The scientific discipline which explores this pharmacological basis of traditional drugs
and poisons is called ethnopharmacology. Its focus ranges from the first-hand
observation of native drug practices (by early travellers and anthropologists) through the
identification of crude ingredients and their constituents (by botanists, zoologists and
chemists) to the evaluation of wanted and unwanted drug effects (by pharmacologists
and toxicologists).
Peter A.G.M. De Smet, Herbs, Health and Healers: Africa as Etbnopbarmacological Treasury 11 (Afrika
Museum 1999).
12. Frants Staugird, Traditional Healers: Traditional Medicine in Botswana 5, 6 (Ipelegang 1985).
13. See Isaac Sindiga, African Etbnomedicine and Other Medical Systems, in Isaac Sindiga, Chacha
Nyaigotri-Chacha, and Mary Peter Kanunah, eds, Traditional Medicine in Africa 16 (East African
Educational 1995).
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doctors and pharmacologists believe that ethnopharmacology yields nothing but
armchair amusement."' 4 In contrast, since 1972, the WHO has consistently called for
an effective integration of traditional medicine into the fabrics of national health care
systems of Member States." Notwithstanding the WHO resolutions, multilateral
health policy still suffers a "regime deficit" because of the tensions between African
ethnopharmacological practices and multilateral malaria control policy.
In our day and age, there are two inextricably linked reasons why ethnomedicine
is relevant to global malaria policy. The first is "global multiculturalism," including its
implications for the health therapy of populations across cultures. The second relates
to the cost and affordability of health care in Africa, where ethnomedical therapies for
malaria may be readily available at a cost the community can afford while orthodox
(Western) malaria medicines may not be. In a multicultural world, every society deals
with illness and disease in a variety of ways. Ethnomedicine has no unifying theme
across societies, thus the therapies it provides vary from one society or culture to
another. Ethnomedical knowledge of plants by indigenous people across societies and
cultures has "long served as crucial sources of medicines either directly as therapeutic
agents, as starting points for the elaboration of more complex semi-synthetic
compounds or as synthetic compounds."6 In most African societies, multiculturalism
has given rise to what some scholars call "medical pluralism"-the existence in a single
society of differently designed and conceived medical systems. Such systems exist
together, and may either compete with, or complement, one another. 7 Populations in
the developing world resort to both traditional medicine and Western medicine
simultaneously for the same illness or at different times for different illnesses."
14. De Smer, Herbs, Health and Healers at 11 (cited in note 11).
15. See World Health Assembly Resolution WHA29.72 (1976) (noting the huge manpower reserve
constituted by traditional medical practitioners); World Health Assembly Resolution WHA30.49
(1977) (calling on Member States to explore the utilization of traditional medicine in their health
care systems); World Health Assembly Resolution WHA31.33 (1978) (noting the medicinal value
of medicinal plants in the health systems of many developing countries).
16. Edith Brown Weiss, In Fairness to Future Generations: International Law, Common Patrimony, and
Intergenerational Equity 266 (Transnational 1989).
17. See David R. Phillips, Health and Health Care in the Third World 75 (Longman Scientific & Technical
1990) (defining medical pluralism as "[t]he existence and use of a wide range of sources of medical
care, traditional and modem, static and evolving"). See also John M. Janzen, The Quest for Therapy:
Medical Pluralism in Lower Zaire (University of California 1978); Horacio Fabrega, Jr., A Commentary
on African Systems of Medicine, in P. Stanley Yoder, ed, African Health and Healing Systems: Proceedings of
a Symposium 238 (Crossroads 1982).
18. See 0. Ampofo and J.D. Johnson-Romauld, Traditional Medicine and its Role in the Development of
Health Services in Africa, in WHO, Technical Discussions of the 25th, 26th and 27tb Sessions of the WHO
Regional Office for Africa, Brazzaville, Congo 51 (WHO 1987) ("African peoples believe in traditional
medicine and it is not uncommon to see patients in hospitals permitting themselves to be treated by
modem medicine during the day and having recourse to the recipes of traditional medicine at
night.').
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Juxtaposing ethnomedicine with Western medicine, the holistic approach of
traditional medicine to the art of healing is one important factor that has continued to
endear it to many of its followers and adherents-a sizeable 80 percent of the
population in most African rural areas. As persuasively argued by one scholar of
ethnomedical approaches in Africa,
[t]he "holistic" concept in traditional healing is commendable, in that the patient's
mind and soul as well as body are considered together during treatment.... One
increasingly important aspect of the African worldview is the belief that human
beings cannot be separated from nature. There is therefore an overwhelming desire
to conquer the natural world or dominate it ... [t]he African worldview is eco-
centric.... It binds humans and the rest of nature together with the same umbilical
cord. 9
John S. Mbiti, a renowned scholar of African religions and philosophy, argued
that diseases and misfortunes are regarded as having social and religious foundations.
The treatment process must therefore go beyond merely addressing their symptoms,
and must address their social implications and develop strategies to prevent their
20
reoccurrence.
Just as ethnomedical therapies differ across societies, the holistic appeal of
traditional medicine is a culturally relative phenomenon. There may be instances
where the relationship between the traditional healer and patient is impersonal.
Nonetheless, the dominant African worldview and the concept of personhood
proffered by scholars like Mbiti and Kalu favor the holistic flavor of traditional
medicine.1
19. Maurice M. Iwu, Preface: Symbols of Power and Health, in De Smet, Herbs, Health and Healers at 9 (cited
in note 11). But see Phillips, Health and Health Care at 81 (cited in note 17). Phillips asserts that
[sitereotypes suggest first, for example, that traditional medicine is holistic, whilst
modern medicine sees only the disease. This might be true in relatively isolated, small-
scale societies, but in large Asian and African villages and towns, there is probably almost
as much impersonal treatment by traditional healers as there is by practitioners of
modern medicine. The holistic appeal of traditional medicine-that it considers the
patient as a whole person, in his or her domestic and social setting-may in fact be
perpetuating a false image.
20. See John S. Mbiti, African Religions and Pbilosopby 162-67 (Heinemann 1969). See also Ampofo and
Johnson-Romauld, Traditional Medicine at 24 (cited in note 18) (arguing that in Africa, disease is not
just a malfunctioning of the body or an organ but essentially a rupture of life's harmony with
nature).
21. In Africa, according to Mbiti, the individual's needs, rights, joys, and sorrows are woven into a social
tapestry that denies singular individuality. Traditional medical practitioners symbolize the hopes of
society: hopes of good health, protection and security from evil forces, prosperity and good fortune,
and ritual cleansing when harm or impurities have been contracted. See Mbiti, African Religions at
166 (cited in note 20). Ogbu Kalu argues that
crucial to indigenous traditions is a religious cosmology with an awareness of the integral
and whole relationship of symbolic and material life... .By sacralizing nature, indigenous
worldviews purvey an ideology which is at once more eco-sensitive, eco-musical and
devoid of the harsh flutes or those who see nature as a challenge to be conquered,
exploited and ruled. They view the environment not in terms of competing interests but
as the playing field on which all other interests intersect.
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Linked to the holistic nature of ethnomedical therapies in the developing world
is the prohibitive cost of orthodox (Western) malaria medicines, emergence of strains
of malaria that resist available Western drugs, and the lack of interest of leading
transnational pharmaceutical companies to research affordable malaria drugs because
of the poor return on investment. All of these factors conspire to make traditional
medicine relevant and popular for malaria treatment in African rural communities.
IV. TRADITIONAL MEDICINE AND MALARIA IN SOUTHEASTERN
NIGERIA: THE VOICES OF RURAL POPULATIONS
The following section focuses on the behavioral attitudes, patterns, and beliefs of
indigenous populations concerning malaria, drawing on a range of semi-structured
interviews conducted while on a short visit to Nigeria in December 2000. My
investigation builds on previous studies of traditional therapies in southeastern
Nigeria. In a study conducted in 1999, Okafor identified 55 plants used in traditional
medicine by 75 percent of rural populations that inhabit the low-lying Ibo heartland
in Eastern Nigeria." Local people use these plants as therapies for a plethora of
diseases and health conditions including malaria and its symptoms.
In the study I conducted, every interviewee admitted to having had malaria many
times in the past, proof that where malaria was endemic, it was a common ailment
that attacked local populations intermittently. An overwhelming 90 percent of the
interviewees said they knew they had malaria if they began to have such symptoms as
pain, severe fever, head and joint aches, loss of appetite, vomiting, dizziness, and
fatigue.' Although their responses are varied, the interviewees described the actions
they took to obtain diagnosis and therapy when they suspected they had malaria.
These actions indicate the popularity of traditional medicine. About 65 percent
consult traditional healers that predominantly use natural herbs and roots as curative
therapies. About 25 percent rely on immediate self-help by seeking out western drugs
from vendors who are popularly called "patent medicine dealers," and the remaining
10 percent consult medical doctors in clinics and hospitals located in the community.
Maurice M. Iwu, Preface Symbols of Power and Health, in De Smet, Herbs, Health and Healers at 9 (cited
in note 11).
22. See Jonathan Okafor and Rebecca Ham, Issues in African Biodiversity No. 3. Identification, Utilization,
and Conservation of Medicinal Plants in Southeastern Nigeria (Biodiversity Support Program 1999) [on
file with CJIL].
23. The symptoms described correspond almost exactly to the symptoms that Western medical science
associates with malaria. See, for example, WHO, Management of Severe Malaria: A Practical Handbook
1 (WHO 2d ed 2000).
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The two groups that rely on self-help or consult medical doctors in clinics/hospitals
admitted to having also consulted traditional healers for treatment in the past.
24
Reasons for resorting to traditional medicine ranged from its relative cheapness
to the ready availability and accessibility of traditional healers in the community.
Consistent with the views of the interviewees, Lateef A. Salako, Director-General of
the Nigerian Institute of Medical Research, observed that
[ijn many parts of Africa, unofficial health care systems and operators exist side by
side with the official system and include herbal healers, medicine vendors and
spiritual healers. These alternative systems are usually more readily accessible and
cheaper than the formal system, and many patients seek treatment from these
groups first, turning to the formal system only when they fail. There is a clear need
to improve the formal system so that it becomes more accessible, acceptable and
affordable to ordinary people and thus becomes their first choice.25
Two traditional healers showed me a collection of herbs and roots that they use as
malaria therapies. The healers have a local name for every herb, bark, or root, and each
therapy is administered in a variety of ways.
One difficult question was how the healers knew that those herbs and roots had
medicinal value. They explained that over the ages, traditional medicine had been
handed down from generation to generation through lineage, family, or even oral
tradition, and that before Western medicine and colonialism arrived in Africa, the
traditional use of herbs for therapies was already established and widely used.
Championing this school of thought, Dr. Raymond Arazu, a Catholic priest and a
leading traditional healer in Eastern Nigeria who uses indigenous herbs for multi-
disease curative therapies, observed:
[t]he plants which God created are there for our needs-their roots, the leaves and
so on. From time immemorial, everywhere, people have used these means to cure
sick people. There are about five different kinds of plants whose leaves when used in
the proper way cure ulcer.... I am only following what my people.., were doing
before this modern craze of the petrochemical drugs which have seemingly replaced
the herbs.26
Observations and responses from healers and interviewees who adhere to
traditional medicines revealed two sets of related facts. First, malaria is an endemic,
life-threatening ailment of the populace. Almost everyone knows what it is, or at least
could correctly guess its symptoms. They call it "iba" in their mother tongue, Igbo.
Second, traditional herbs exist, and are readily available within the community's
24. Dr. Okafor stated that about 40 percent of his malaria patients are brought to the clinic with severe
and sometimes life-threatening cerebral illnesses after having visited traditional healers in search of
therapies. Interview with Dr. I.P.S. Okafor, Medical Director of St. Victoria Hospital, Ekwulobia,
Anambra State, Nigeria (Dec 18, 2000).
25. Lateef A. Salako, An African Perspective, 3 World Health 24 (May-June 1998).
26. Interview with Reverend Father Raymond Arazu, 120 The Torch (Biannual Publication of the
Students of Bigard Memorial Seminary, Enugu, Nigeria) 37, 38-39 (Dec 2000-Jun 2001) (on file
with CJIL].
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forests for its treatment. These facts are consistent with the predominant worldview
of the Ibo ethnic group in Eastern Nigeria as mirrored by the world acclaimed novelist
Chinua Achebe in his famous work, Things Fall Apart. In the book, the fictional
Okonkwo applied therapies from a bundle of "grasses and leaves, roots and barks of
medicinal trees and shrubs" to his daughter who suffered from iba (malaria). The type
of ethnomedical therapy described by Achebe abounds in almost every African society
where malaria is endemic.' These therapies have existed for ages and are still alive
today. They have a sizeable number of adherents and many men and women, like
Okonkwo, are repositories of this knowledge. Such traditional therapies interact with
modern medicine in an environment of medical pluralism.
For these reasons, it is pertinent to evaluate the interaction between traditional
malaria therapies and global malaria control policy. This evaluation will be conducted
within the paradigmatic frameworks of "globalization-from-above" and "globalization-
from-below."
V. MULTILATERAL MALARIA CONTROL STRATEGIES:
GLOBALIZATION-FROM-ABOVE OR GLOBALIZATION-FROM-BELOW?
Richard Falk coined the terms globalization-from-above and globalization-from-
below as operational paradigms to explore the dimensions of emergent global
governance in a world order marked by the Westphalian model of statehood.
Contemporary global governance has witnessed tensions between states on the one
side, and a coalition of transnational civil society on the other. Global policies
incubated at multilateral fora by states acting as harbingers and repositories of
political power within geopolitical boundaries often run counter to civil society
oriented ideals.
Falk proposes a framework aimed at the animation of civil society in relation to a
transnational agenda involving human rights, environmental protection, public health,
social and economic justice, disarmament, and other substantive areas in which global
market forces and states are perceived to be endangering human well-being. These
civic pressures constitute a formidable challenge to governments to be more protective
of global public goods. The multiple dimensions of this civic society challenge come
within the rubric of globalization-from-below. In sharp contrast, the contemporary
global social and environmental agendas are often detrimental to a range of public
goods. This latter phenomenon, driven by market forces in coalition with most
governments, is attributed to globalization-from-above.'
27. See Chinua Achebe, Things Fall Apart 66-86 (Heinemann 1958). Consider the protagonist
Okonkwo's role as a repository of ethnomedical knowledge regarding malaria in illustrating how his
worldview related to traditional and contemporary malaria therapies.
28. See Falk, Law in an Emerging Global Village at 216 (cited in note 2).
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Globalization-from-below does not constitute a kind of teleological
cosmopolitanism. Its agenda does not foresee the extinction of the Westphalian state,
neither does it envision the nation-state as completely irrelevant in global governance
dynamics. Rather it proposes the urgent development of a symbiotic framework based
on a dialogue between emergent transnational civil society forces and states as
repositories of political leadership and power. Relying on theorists like Koskenniemi
and Habermas, Falk argues:
[D]ialogue here is not just words, but the foundation of communicative action that
is the essence of democratic practice. . . . Given the structure of international
society, and its continuing adherence to a strong doctrinal view supportive of
sovereign rights, the most appropriate role for the jurist is to avoid the temptations
of apoiogetics or of utopianism, neither relinquishing juridical autonomy to the
political domain nor setting forth legalistic positons that are dismissed as pathetic
fantasy by those entrusted with the responsibilities of political leadership..-.
[Ijnternational law and lawyers can best contribute to the prospects of fashioning a
more humane type of global civilization by self-confidently entering the dialogic
space between entrenched political power and transnational social forces
acknowledging the relevance of both, but subordinating their autonomy to neither."
Applied analogously to the interaction between people or civil-society-oriented
traditional malaria therapies (globalization-from-below) and malaria control policies
of multilateral agencies (globalization-from-above), the pertinent task is to explore
whether the dialogue between the two has occurred, is indeed occurring now, or will
likely occur in the near future.
Traditional medicine is generally endorsed by the WHO, which has called on
countries to integrate traditional medicine within their national health care systems.
In its World Health Report 2000, which focused on improving the performance of health
systems, the WHO defined a health system to include "all the activities, whose
primary purpose is to promote, restore or maintain health."" According to the WHO,
formal health services, including the professional delivery of personal health attention
and actions by traditional healers are clearly within the boundaries of this definition.
In a seminal article, David Nabarro, former Project Director of RBM, stated
that
[w]ithin developing countries, the private sector (whether in the form of a licensed
medical practitioner, private pharmacy, or traditional healer) is very often the main
source of advice and treatment for all people, including the poor. Government
health services will need to acknowledge this and develop better ways of working
with and regulating the different types of practitioners to provide essential public
health services."
29. Id at 206-07.
30. World Health Organization, The World Health Report 2000: Health Systems: Improving Performance 5
(WHO 2000).
31. David N. Nabarro and Elizabeth M. Taylor, The "Roll Back Malaria" Campaign, 280 Science 2067,
2068 (une 26, 1998).
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Despite this tacit recognition of traditional medicine by the WHO, it is curious
that nothing in either the RBM Campaign or its sister partnership, the MMV,
expressly mentions the integration of traditional malaria therapies as part of its
operational framework.
The visions of both RBM and MMV are commendable for their innovative
public-private sector partnership and governance of malaria. Nevertheless, their
visions would remain flawed if their reach systematically relegated traditional medical
therapies to the peripheries of global malaria governance. The prevailing emphasis on
insecticide-treated bed nets (in the case of RBM) and production of new malaria
drugs every five years (in the case of MMV) has forced the WHO to enter into joint
ventures with corporate entities to foot the bill of implementing these multilateral
strategies. These agreements cloak the corporate entities involved with a sacrosanct
juristic and corporate veil marked by absolute autonomy that cannot be challenged by
WHO member states, transnational civil society networks, or local populations who
live with the burdens of malaria.
As Yamey observed, "[o]ne problem with huge global partnerships [like RBM]
is that.., they end up being accountable to nobody. One function of reporting their
meetings and activities is to expose them to s6me sort of scrutiny and help them
become accountable to those they serve."32 In this sense, both the RBM and MMV
can easily be guilty of globalization-from-above.
Moving forward, I propose an immediate dialogue, in the policy arena, between
civil-society-oriented traditional approaches to malaria and governments within
national jurisdictions in malaria-endemic countries. The dialogue within countries
would aim at what I call the scientification of traditional malaria therapies." What
emerges from the dialogue within countries would transcend national jurisdictions
and forge transnational dialogues aimed at evolving an inclusive malaria globalism
based on multi-stakeholder participation.
My proposition for the scientification of traditional malaria therapies does not
necessarily mean that scientification will follow the analytical progression and
methodology of western science. Science, in some sense, is multicultural, and the
multiculturalism of science applies to traditional herbal medicine in most parts of the
developing world. In other aspects of traditional medicine where the multiculturalism
of science cannot easily be established and extrapolated across diverse cultures, there is
a need for further and continuous dialogue between civil society networks and states
32. Yamey, 322 Brit MedJ at 1192 (cited in note 10).
33. This proposal is not novel, as many countries have initiated a process of harmonizing traditional
medical therapies with Western medicine. This is done by incorporating aspects of traditional
healing practices, mainly with herbs and roots that are scientifically proven to have medicinal value,
as part of national health care systems. See, for example, Murray Last and G.L. Chavundika, eds,
The Professionalisation of African Medicine (Manchester 1986) (giving a useful overview of the prospects
and ambiguities of traditional medicine across African societies).
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to forge a synthesis. In other words, an epidemiological fertilization of ideas across
multilateral, transgovernmental, and transcivil society networks is urgently needed.
This may be the only viable path to a humane multilateral malaria governance
founded on an activation of people-oriented medical therapies, achieving the more
desirable form of globalization-from-below.
VI. IS SCIENCE MULTICULTURAL?: FAIRNESS, LAW, INTELLECTUAL
PROPERTY, AND TRADITIONAL MEDICINE
Most of the herbs used for ages by populations in Africa, Asia, and Latin
America as traditional therapies for ailments (including malaria) have now been
universally acclaimed as having medicinal and scientific value.' There are many
examples of appropriation of indigenous scientific knowledge. Quinine, a well-known
and universally acclaimed cure for malaria, comes from the bark of the Peruvian
cinchona tree. Andean indigenous populations used quinine as a cure for fevers,
supposedly learning of its medical efficacy by observing feverish jaguars eating it.
Other notorious examples of Western appropriation include the rosy periwinkle
plant, unique to Madagascar, which contains properties that combat certain cancers.
The anti-cancer drugs vincristine and vinblastine have been developed from the
periwinkle, resulting in over $100 million in annual sales for Eli Lilly and virtually
nothing for Madagascar. In the same fashion, a barley gene that resists the yellow-
dwarf virus has been the product of breeding and cultivation by Ethiopian farmers for
centuries. Scientists and farmers in the United States patented the barley variety and
now receive enormous profits from its current cultivation in the US, but the
Ethiopian farming communities that originally developed the variety receive nothing.
The protection of traditional medicine (indigenous herbs and plants that have
medicinal value) within the regime of intellectual property has been intensely
controversial and politicized in recent years." Those not wishing to extend patent
protection to traditional medicine may claim that traditional medicine is not novel and
therefore does not meet the requirements for a patent; or believe that the desire to
increase access to medicines is satisfied by limiting the number of patents granted.6
34. See Naomi Roht-Arriaza, Of Seeds and Shamans: The Appropriation of the Scientific and Technical
Knowledge of Indigenous and Local Communities, 17 Mich J Intl L 919, 920-27 (1996) (noting that
many of today's common remedies were often first developed by healers prior to contact with
industrial societies).
35. For works that explore indigenous knowledge from intellectual property perspectives, see Eug~nio
Da Costa E Silva, The Protection of Intellectual Property for Local and Indigenous Communities, 17 Eur
Intel Prop Rev 546 (1995); Alan S. Gutterman, The North-South Debate Regarding the Protection of
Intellectual Property Rights, 23 Wake Forest L Rev 89 (1993); R. Michael Gadbaw and Timothy J.
Richards, Intellectual Property Rights: Global Consensus, Global Conflict? (Westview 1998).
36. See Carlos Correa, Integrating Public Health Concerns into Patent Legislation in Developing Countries 28
(South Centre 2000).
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Although the issue of protection of traditional knowledge arises in a range of
multilateral normative and conventional provisions,37 patentability requirements under
the World Trade Oragnization's Agreement on Trade-Related Aspects of Intellectual
Property Rights ("TRIPS") have overshadowed debates on the modus operandi of
such protection in the multilateral arena.
To pass the patentability test under the TRIPS Agreement, Article 27 requires
an inventor to prove that his invention is new (novelty), shows an "inventive step" (the
invention was non-obvious), and that the invention is industrially applicable.
Following these requirements, some scholars have suggested that holders of
traditional medical knowledge face three major impediments to obtaining patent
protection. First, most traditional medical knowledge is ancient and therefore does
not meet the requirements of novelty and inventive step. Second, traditional medical
knowledge is held collectively; there is no single individual or group of individuals that
can be identified as an inventor in whose name the application may be filed. Third, the
complexity and cost of patent applications are beyond the reach of traditional
knowledge holders.' The veracity or otherwise of these contentions is beyond the
scope of this article; nonetheless, a relevant question remains: how do we develop a fair
international regime that protects indigenous medical knowledge held for generations
by societies in the developing world?
The conundrum here is to reconcile the provisions of Article 80) of the
Convention on Biological Diversity with the novelty and inventive step requirements
of TRIPS Article 27. One way to mitigate the harshness of the novelty/inventive step
requirements under TRIPS is to adopt a sui generis model law for "minor" inventions
that fail to meet these requirements." While I agree with this view, it is of utmost
importance that such sui generis laws have the capacity to prevent "biopiracy" of the
previous decades that was the hallmark characteristic of the examples offered by Roht-
Arriaza.4° Effective protection of traditional medical knowledge must strive to
equitably match the so-called "moral victory" of the global South under the
37. For instance, Article 80) of the United Nations Convention on Biological Diversity provides that
each contracting party shall, as far as possible and as appropriate,
[s]ubject to its national legislation, respect, preserve and maintain knowledge, innovations
and practices of indigenous and local communities embodying traditional lifestyles
relevant for the conservation and sustainable se of biological diverity and promote their
wider application with the approval and involvement ofthe holders of such knowledge,innovations, and practices and encourage the equitable sharing of the benefits arisingfrom the utilization of such knowledge, innovations and practices.
38. See Richard Wilder, Protection of Traditional Medicine 21 (WHO 2001).
39. See Correa, Integrating Public Health Concerns at 28 (cited in note 36).
40. Although no unanimous universal definition of"biopiracy" exists, I use it in this context to refer to
the immoral practice whereby Western pharmaceutical corporations reap unjustifiable profit from
traditional medical knowledge, therapies, and practices held by communities in the developing world
for ages by claiming the invention and patent of those therapies and products. See the examples
offered by Roht-Arriaza, 17 MichJ Intl L at 920-27 (tired in note 34).
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Convention on Biological Diversity with the "legal victory" of the North under
TRIPS.
VII. SUMMARY OF THE ARGUMENTS: TOWARDS A HUMANE
MULTILATERAL MALARIA REGIME
One of the formidable challenges of multiculturalism is to reconcile the tensions
between the core of multilateral health regime and the peripheries. Using multilateral
malaria control policy as the subject of analysis and inquiry, this article has explored
the relevance of indigenous malaria therapies in a medically pluralistic world-a
global policy universe where public health presents various challenges that continue to
require multilateral and multicultural approaches. What emerges from this analysis is
a largely irreconcilable tension between the core (global malaria control policy) and
the peripheries (indigenous malaria therapies widely used by populations in malaria
endemic regions of the developing world). Given that the core and the peripheries are
bound together, any degree of tension in their co-existence inevitably leads to
turbulence in global health governance.
In an attempt to harmonize the core and the peripheries, this article identifies
three useful approaches: the "scientification" of traditional medical therapies in the
developing world, global governance mechanisms that respect globalization-from-
below, and the protection of traditional medical knowledge within the corpus juris of
intellectual property.
The core of these approaches lies in the activation of people or civil-society-
oriented approaches to multilateral health governance. Ethnomedicine is not just
magic, superstition, or witchcraft, but an age-old health delivery system widely used
by a sizeable percentage of populations in the developing world. Because alternative
medical therapies are either unaffordable to or unpopular among these populations,
continued relegation of African ethnomedicine to the peripheries of global malaria
regime is unabashedly discriminatory. Although commendable, the vision of
contemporary multilateral malaria control strategies-the RBM Campaign and
MMV-ought to be sensitive to the constituencies they serve: indigenous
communities in malaria endemic societies where the mortality and morbidity burdens
of the disease are heaviest. RBM and MMV partnerships must rapidly go beyond the
concerns of insecticide-treated bed nets and affordable new malaria drugs. They must
now respond to the behavioral patterns of local populations to indigenous malaria
therapies.
How best then can this regime deficit be closed? We need a more inclusive and
multi-stakeholder approach to multilateral malaria control policy. To ensure stability
and peace in the global neighborhood, innovative approaches to multilateral malaria
governance must harmonize the tensions between the core global malaria control
regime and the traditional therapies at the margins in a way that projects
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multilateralization of malaria as humane and equitable, rather than as a predatory
enterprise.
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